Mithra Pharmaceuticals S.A.

MITPF · OTC
Analyze with AI
12/31/2023
6/30/2023
12/31/2022
6/30/2022
Operating Activities
Net Income-$123-$50-$28-$31
Dep. & Amort.$6$6$6$6
Deferred Tax$46$40-$38-$19
Stock-Based Comp.$5$0$1$0
Change in WC-$63$52-$24-$7
Other Non-Cash$118-$38$55$12
Operating Cash Flow-$11$9-$29-$38
Investing Activities
PP&E Inv.$0-$6-$13-$12
Net Acquisitions$0$0-$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$10$0$0
Other Inv. Act.$1-$2-$0-$9
Investing Cash Flow$1$2-$13-$12
Financing Activities
Debt Repay.$0-$18$0-$2
Stock Issued$0$3$1$49
Stock Repurch.-$3$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2$2$41$49
Financing Cash Flow-$5-$16$41$47
Forex Effect$0-$0-$0-$0
Net Chg. in Cash-$15-$5-$1-$4
Supplemental Information
Beg. Cash$24$28$29$33
End Cash$9$24$28$29
Free Cash Flow-$11$3-$42-$50
Mithra Pharmaceuticals S.A. (MITPF) Financial Statements & Key Stats | AlphaPilot